Jade Biosciences, Inc. Common Stock

JBIONASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
16.94 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
16.90
↘ 0.04 (0.24%)
POST MARKET (AS OF 04:26 PM EDT)
Post Market
AS OF 04:26 PM EDT
16.90
↘ 0.04 (0.24%)
🔴Market: CLOSED
Open?$17.52
High?$18.23
Low?$16.51
Prev. Close?$16.94
Volume?2.6M
Avg. Volume?820.6K
VWAP?$17.20
Rel. Volume?3.17x
Bid / Ask
Bid?$16.05 × 1.0K
Ask?$18.00 × 1.2K
Spread?$1.95
Midpoint?$17.03
Valuation & Ratios
Market Cap?836.2M
Shares Out?49.4M
Float?41.4M
Float %?83.9%
P/E Ratio?N/A
P/B Ratio?2.82
EPS?-$2.33
Dividend?0.00%
Ex-Dividend?N/A

Jade Biosciences, Inc. Common Stock (JBIO) trades at $16.91 per share. Technical indicators currently signal "Sell". This is driven by negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest JBIO is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Themes
Biotech - Drug Development›Immunology & AutoimmuneBiotech - Drug Development›Rare Disease Therapeutics
Employees
55
Market Cap
1.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.jadebiosciences.com
Listed
2025-04-29
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: (781) 312-3013
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?8.21%Elevated
Short Interest?3.4M
Days to Cover?7.7
Free Float41.4M
Avg Daily Volume443.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?14.29Strong
Quick Ratio?14.29Strong
Cash Ratio?2.47Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
59
2.82CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-38.8%WEAK▾
ROA?
S&P
3
-36.0%WEAK▾
Cash Flow & Enterprise
FCF?$-101690000
Enterprise Value?$781.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist